J. Goldman & Co’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-656,161
| Closed | -$5.4M | – | 427 |
|
|
2022
Q3 | $5.4M | Sell |
656,161
-662,260
| -50% | -$5.45M | 0.26% | 77 |
|
|
2022
Q2 | $8.65M | Buy |
1,318,421
+8,455
| +0.6% | +$55.5K | 0.42% | 40 |
|
|
2022
Q1 | $7.32M | Buy |
1,309,966
+89,208
| +7% | +$499K | 0.33% | 53 |
|
|
2021
Q4 | $5.73M | Sell |
1,220,758
-442,471
| -27% | -$2.08M | 0.32% | 60 |
|
|
2021
Q3 | $10.3M | Sell |
1,663,229
-157,947
| -9% | -$976K | 0.51% | 29 |
|
|
2021
Q2 | $12M | Buy |
+1,821,176
| New | +$12M | 0.47% | 34 |
|